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Conditional deletion of the mouse Forkhead Box (Fox) m1b targeted allele in adult hepatocytes (Foxm1, previously called HFH-11B,
Trident, Win, or MPP2) demonstrated that the Foxm1b transcription factor is essential for hepatocyte mitosis during liver regeneration. To
determine the role of Foxm1b in liver development, we have generated Foxm1b / mice that deleted the Foxm1b exons encoding the
winged helix DNA binding and transcriptional activation domains. Here, we show that all of the Foxm1b / embryos died in utero by 18.5
days postcoitum (dpc). Embryonic Foxm1b / livers displayed a 75% reduction in the number of hepatoblasts, resulting from diminished
DNA replication and a failure to enter mitosis causing a polyploid phenotype. Reduced hepatoblast mitosis was associated with decreased
protein levels of the Polo-like kinase 1 and Aurora B kinase, which phosphorylate regulatory proteins essential for orchestrating mitosis and
cytokinesis. Diminished proliferation of Foxm1b / hepatoblasts contributed to abnormal liver development with significant reduction in
the number of large hepatic veins compared to embryonic wild-type (WT) liver. Furthermore, embryonic Foxm1b / livers did not develop
intrahepatic bile ducts, and these presumptive biliary hepatoblasts failed to express either biliary cytokeratins or nuclear levels of hepatocyte
nuclear factor 1h. These results suggest that Foxm1b is critical for hepatoblast precursor cells to differentiate toward biliary epithelial cell
lineage. Finally, we used a hepatoblast-specific Cre recombinase transgene to mediate deletion of the Foxm1b fl/fl allele in the developing
liver, and these embryos died in utero and exhibited diminished hepatoblast proliferation with similar abnormalities in liver morphogenesis,
suggesting that the defect in liver development contributed to embryonic lethality.
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During mouse embryogenesis, the liver bud begins to
develop at 8.5 days postcoitum (dpc) as a proliferative
outgrowth from the ventral foregut endoderm. Initiation of
hepatic specification of the ventral foregut endoderm results
from convergent signaling of both bone morphogenetic
proteins (BMPs) originating from the septum transversum
mesenchyme and fibroblast growth factors (FGFs) released276 (2004) 74–88
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Primitive hepatic cells derived from the cranial part of the
liver primordium proliferate, delaminate from the foregut
endoderm, and invade the septum transversum mesenchyme
(Duncan, 2003; Zaret, 2002). Between 13 and 15 dpc, the
embryonic liver is composed of bipotential hepatoblasts,
which are arranged in hepatic cords and can differentiate
toward either the hepatocytic or biliary epithelial cell
lineages (Duncan, 2003; Lemaigre, 2003; Zaret, 2002). At
15 dpc, hepatoblasts that coalesce around the portal
mesenchyme begin to express biliary cytokeratin proteins
and then undergo a complex morphogenesis process
culminating in the formation of intrahepatic bile ducts
(IHBD) by 17.5 dpc (Lemaigre, 2003). At this stage of liver
development, differentiating hepatocytes acquire polarized
epithelial cell morphology, which coincides with the
induction of hepatocyte nuclear factor 4a (Hnf4a) target
genes encoding proteins required for gluconeogenesis,
glycogen synthesis, and epithelial cell tight junctions and
epithelial cell adhesion (Parviz et al., 2003). Sinusoids lined
with fenestrated endothelial cells develop on the hepatocyte
basolateral membrane, and bile canaliculi form on the apical
hepatocyte membrane (Duncan, 2003; Zaret, 2002). In the
adult liver, bile is synthesized in hepatocytes, secreted into
the bile canaliculi, and flows through the IHBD into the
hepatic and cystic duct to the gall bladder for storage
(Erlinger, 1996; Lemaigre, 2003). In response to the
hormone cholecystokinin, bile is released from the gall
bladder into the digestive tract to emulsify lipids.
At 15.5 dpc, HNF6 protein is expressed at high levels in
hepatoblasts adjacent to the portal mesenchyme and in the
epithelial cells of the extrahepatic bile ducts and gall bladder
with lower HNF6 expression in hepatoblasts of the liver
parenchyma (Clotman et al., 2002). Consistent with this
expression pattern, Hnf6 / mouse embryos fail to
develop a gall bladder and exhibited severe abnormalities
in both extrahepatic and intrahepatic bile ducts, which was
associated with diminished expression of the Hnf1b tran-
scription factor (Clotman et al., 2002; Jacquemin et al.,
2000). Interestingly, use of the a-fetoprotein enhancer
albumin promoter–enhancer-driven Cre recombinase trans-
gene (AFPp-Cre) to delete the Hnf1b LoxP (Floxed)
targeted allele in hepatoblasts caused developmental abnor-
malities in the gall bladder and IHBD similar to but less
severe than those found in the Hnf6 / mouse embryos
(Coffinier et al., 2002). These studies demonstrate that
HNF6 is essential for regulating expression of Hnf1b, which
then plays an important role in development of the gall
bladder and IHBD.
The mammalian Forkhead Box (Fox) family of tran-
scription factors consists of more than 50 mammalian
proteins (Kaestner et al., 2000) that share homology in the
winged helix DNA binding domain (Clark et al., 1993). The
Foxm1b protein (or Foxm1, previously known as HFH-11B,
Trident, WIN, or MPP2) is a proliferation-specific member
of the Fox family of transcription factors (Korver et al.,1997; Luscher-Firzlaff et al., 1999; Yao et al., 1997; Ye et al.,
1997). During liver regeneration, Foxm1b expression is
markedly induced at the G1/S transition and continues
throughout the period of hepatic cell proliferation (Ye et al.,
1997). Use of the transthyretin (TTR) promoter to
prematurely express the Foxm1b (HFH-11B) cDNA in
regenerating liver of transgenic (TG) mice accelerated the
onset of hepatocyte DNA replication and mitosis by
stimulating earlier expression of cell cycle regulatory genes
(Costa et al., 2003; Wang et al., 2001a; Ye et al., 1999). To
prevent the decline of Foxm1b expression during liver
regeneration in 12-month-old (old-aged) mice, we previ-
ously used either the TTR-Foxm1b transgene (Wang et al.,
2001b), adenovirus delivery of Foxm1b to the liver (Wang
et al., 2002b), or growth hormone-mediated increase in
Foxm1b expression (Krupczak-Hollis et al., 2003). These
liver regeneration studies with old-aged mice demonstrated
that increased Foxm1b expression stimulated proliferation
of old-aged hepatocytes to levels found in young regenerat-
ing liver. Conditional deletion of the Foxm1b LoxP/LoxP
(fl/fl) targeted allele in adult hepatocytes using the albumin
promoter–enhancer Cre recombinase (Alb-Cre) demonstra-
ted that Foxm1b is essential for hepatocyte DNA replication
and mitosis following partial hepatectomy (Wang et al.,
2002a). Reduced hepatocyte proliferation was associated
with increased nuclear protein levels of Cdk inhibitors
p21Cip1 and p27Kip1 and reduced protein expression of
Cdc25B phosphatase, leading to decreased Cdk1 and Cdk2
activation required for cell cycle progression (Kalinichenko
et al., 2004; Wang et al., 2002a). Furthermore, Alb-Cre
Foxm1b / hepatocytes fail to proliferate and are highly
resistant to formation of hepatocellular carcinoma in
response to a diethylnitrosamine (DEN)/phenobarbital
(PB) liver tumor induction protocol (Kalinichenko et al.,
2004).
Previous studies described the generation of mice con-
taining a Foxm1b (Trident) targeted allele that inserted the
PGK-neomycin gene cassette into the third Foxm1b exon
without deleting any of the coding exons (Korver et al.,
1998). This insertion into the third exon preceded the
Foxm1b exons encoding the winged helix DNA binding
and transcriptional activation domains. Although these
authors reported on a polyploid phenotype in embryonic
Foxm1b / hepatoblasts and cardiomyocytes, no embry-
onic lethality was found, yet all of the Foxm1b / pups
died postnatally presumably from circulatory failure (Korver
et al., 1998). Moreover, this Foxm1b / embryonic study
did not analyze the morphological defects in the developing
liver nor did they provide the molecular mechanisms
involved in this polyploid phenotype (Korver et al., 1998).
Here, we created a complete null Foxm1b allele using
the EIIa-Cre recombinase (Lakso et al., 1996) to delete
exons 4 to 7 encoding the winged helix DNA binding and
transcription activation domains from the mouse Foxm1b
fl/fl targeted allele (Major et al., 2004; Ye et al., 1997).
These Foxm1b / embryos died in utero and exhibited
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significant reduction in hepatoblast mitosis causing a
polyploid phenotype. We showed for the first time that
Foxm1b is essential for expression of Polo-like kinase and
Aurora B kinase, which phosphorylate regulatory proteins
of the mitotic machinery that mediate chromosome
condensation and alignment, mitotic spindle assembly,
and cytokinesis (Adams et al., 2001; Carmena and Earn-
shaw, 2003; Glover et al., 1998; Shannon and Salmon,
2002). Diminished proliferation of embryonic Foxm1b
/ hepatoblasts contributed to abnormal liver develop-
ment with defects in IHBD formation and disruption in
organization of hepatic cords and sinusoids and significant
reduction in the number of large hepatic veins compared to
wild-type (WT) liver.Materials and methods
Foxm1b / and AFPp-Cre Foxm1b fl/fl mice
Generation of the mice containing the Foxm1b LoxP/
LoxP (fl/fl) targeted allele, which were bred into the C57/B6
background for four generations, was described previously
(Wang et al., 2002a). Mice homozygous null for the
Foxm1b gene were generated by mating Foxm1b Floxed
(fl/fl) mice to EIIa promoter-driven Cre recombinase trans-
genic mice (EIIa-Cre), which drives transient expression of
Cre recombinase during the blastocyst stage of mouse
development (Lakso et al., 1996). This cross produces
chimeric mice that contain all of the potential deletions of
the sequences between the LoxP sites in the targeted
Foxm1b fl/fl allele. Male mice generated from this cross
that lacked the EIIa-Cre transgene were bred with wild-type
(WT) mice to generate Foxm1b +/ offspring. The Foxm1b
deleted allele was identified by Southern blot analysis as
described previously (Wang et al., 2002a). PCR analysis
was used to screen for the Foxm1b deleted allele with a
sense primer made to Foxm1b third intron sequence located
5Vto LoxP insertion: 5V-tggcttcccagcagtacaaatc-3Vand anti-
sense Foxm1b genomic sequences located 3Vto the LoxP-
PGK-Neo-LoxP selection cassette: 5V-tctcgctcaattccaagac-
cag -3V(see Fig. 1A). Deletion of Foxm1b exons 4 to 7 in
the deleted allele brings these primers in close proximity,
allowing production of a 400-nucleotide PCR product.
To determine timing of embryonic development, male
mice were mated with female mice in the evening, and
vaginal plugs were checked in the morning. Noon of the day
of appearance of a vaginal plug was designated as 0.5 days
postcoitum (dpc). Foxm1b +/ mice were bred to harvest
Foxm1b / embryos from pregnant mothers for analysis.
Pregnant mothers were sacrificed by carbon dioxide
asphyxiation at various days of gestation, and the embryos
were removed by cesarian section. Internal cartilage tissue
samples were used for genotyping the Foxm1b allele by
PCR analysis. Two hours before sacrifice, an IP injection ofPBS containing 10 mg/ml 5-bromo-2V-deoxyuridine (BrdU,
Sigma; 50 Ag/g body weight) was administered to pregnant
mothers.
Conditional knockout mice containing hepatoblast-
specific deletion of the Foxm1b fl/fl allele were generated
by breeding Foxm1b LoxP/LoxP (fl/fl) mice to Tg(Alb1-
cre)Khk transgenic mice expressing Cre recombinase
under the control of the a-fetoprotein (AFP) enhancer
and albumin promoter and enhancer (AFPp-Cre). Original
matings used Foxm1b fl/fl females to breed with AFPp-
Cre Foxm1b fl/+ males, resulting in a portion of the
embryos with the AFPp-Cre Foxm1b fl/fl genotype.
Although 70% of AFPp-Cre Foxm1b fl/fl embryos die in
utero by 15.5 dpc, some AFPp-Cre Foxm1b fl/fl embryos
survived through birth and were capable of mating due to
incomplete deletion of the targeted allele as described
previously (Parviz et al., 2002). To allow for a larger
number of AFPp-Cre Foxm1b fl/fl embryos per litter,
surviving AFPp-Cre Foxm1b fl/fl males were subsequently
mated to female Foxm1b fl/fl mice. Hepatoblast-specific
deletion of the Foxm1b fl/fl allele was verified by using
embryonic liver genomic DNA for Southern blot analysis
and PCR analysis as previously described previously and
above (Wang et al., 2002a).
Immunohistochemical and immunofluorescent staining
Livers from 13.5- to 18.5-dpc embryos were harvested
and paraffin-embedded after overnight fixation with 10%
buffered formalin. Five-micrometer paraffin liver sections
were stained with hematoxylin and eosin (H&E) for
morphological examination or used for immunohistochem-
ical and immunofluorescent staining with antibodies as
described previously (Kalinichenko et al., 2001). Paraffin
sections were subjected to immunohistochemical staining
using albumin (1:1000 rabbit polyclonal, DAKO), HNF4a
(1:500 goat polyclonal Santa Cruz), HNF1h (1:250 goat
polyclonal Santa Cruz), or Gata4 (1:100; C-20, goat
polyclonal Santa Cruz) antibodies as previously described
(Parviz et al., 2002). The hepatoblast nuclei in HNF1h- and
albumin-stained liver sections were counterstained with
hematoxylin. Immunohistochemical staining of liver sec-
tions using activated cleaved caspase 3 antibody was
performed as previously described (Kalinichenko et al.,
2003). To visualize biliary epithelial cells, mouse mono-
clonal cytokeratin antibody (clone PCK-26, Sigma) was
used as previously described (Kalinichenko et al., 2002).
Determination of the number of hepatoblasts undergoing
DNA replication and the number of hepatic veins per mm2
of tissue
To determine the relative number of hepatoblasts in
embryonic livers studied, paraffin-embedded sections were
subjected to immunohistochemical staining using HNF4a
antibody as described above. The number of HNF4a-
Fig. 1. Foxm1b-deficient livers contain reduced number of vessels. (A) Mice containing the Foxm1b LoxP/LoxP (fl/fl) targeted allele with exons 4 and 7 of the
Foxm1b allele flanked by a LoxP site and LoxP PGK-Neo LoxP selection cassette were described previously (Wang et al., 2002a). We mated the a-fetoprotein
(AFP) enhancer and albumin promoter and enhancer Cre recombinase (AFPp-Cre) transgenic mice (Parviz et al., 2002) with Foxm1b fl/fl mice to generate a
hepatoblast-specific deletion of the Foxm1b fl/fl allele. We mated the blastocyst-specific EIIa promoter Cre recombinase (EIIa-Cre) transgenic mice (Lakso et
al., 1996) with Foxm1b fl/fl mice to generate a ubiquitous deletion of the Foxm1b fl/fl targeted allele gene. This results in deletion of Foxm1b exons 4 to 7
encoding the winged helix DNA binding domain and the C-terminal transcriptional activation domain. (B) PCR analysis of Foxm1b /, +/, and +/+
embryos with primers depicted in A. The primers for detection of the Foxm1b deleted allele are shown by arrows (brown), and primers 1 and 3 are brought into
close proximity following deletion of Foxm1b exons 4 to 7 and therefore produce a 400-nucleotide PCR product only from the deleted Foxm1b (/) allele.
The Foxm1b / allele removes sequences homologous to primer 2, and therefore primer 1 and 2 will only produce a 230-nucleotide PCR product from the
wild-type (WT) Foxm1b allele. (C) RNase protection assays demonstrating that Foxm1b / livers display undetectable levels of Foxm1b mRNA. (D) Picture
of 17.5-dpc WT (+/+) or Foxm1b / (/) embryo. (E) Graphic representation of the mean number of large hepatic veins per mm2 of embryonic liver tissue
(FSD) that was calculated from hematoxylin & eosin (H&E)-stained liver sections from either WT or Foxm1b / embryos.
K. Krupczak-Hollis et al. / Developmental Biology 276 (2004) 74–88 77positive hepatoblasts was counted for three 400 fields of
embryonic liver sections for each mouse and plotted on the
graph. At least three mice were counted for each genotype.
To determine the number of hepatoblasts undergoing DNA
replication, 5-Am liver sections were subjected to double
immunofluorescence using monoclonal BrdU antibody(DAKO) visualized with antimouse antibody conjugated
with FITC and polyclonal albumin (DAKO) antibody
visualized with anti rabbit antibody conjugated with TRITC
as described previously (Kalinichenko et al., 2004). The
number of BrdU- and albumin-positive cells was counted
per 100 albumin positive cells using three different liver
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calculate the mean number of BrdU- and albumin-positive
hepatoblasts F SD. We also used rabbit polyclonal anti-
bodies against phosphohistone H3 antibody (PH-3; Upstate;
Catalog # 06-570) and detected the antibody–antigen
complex using antirabbit antibody conjugated with FITC
(Vector Laboratory), which decorates condensed chromo-
somes at the early stages of mitosis. We counted the number
of large veins per mm2 of liver tissue using H&E-stained
liver sections from 15.5- and 18.5-dpc Foxm1b / and
WT embryos. We used at least five different liver sections
for counting the veins from three different 15.5-dpc mouse
embryos or two different 18.5-dpc mouse embryos to
calculate the mean number of large veins per mm2 of liver
tissue F SD.
RNase protection assay and Western blot analysis
For Western blot analysis, 50 to 75 Ag of total protein
extracts prepared from embryonic livers (Rausa et al., 2000;
Wang et al., 2002a,b) was separated on SDS–PAGE and
transferred to PVDF membrane (BioRad). The signals from
primary rabbit antibodies specific to either Cdc25B, Cdk1,
Cdk2 (Santa Cruz Biotech, 1:500), albumin (DAKO,
1:5000), or HNF-6 (1:500) proteins (Rausa et al., 2000).
We also used mouse monoclonal antibodies specific to
either h-actin (clone AC-15; Sigma; 1:30,000 dilution),
Polo-like kinase (Santa Cruz Biotech, 1:500), or Aurora B
kinase proteins (AIM-1; BD Transduction laboratories,
Catalog # 811062; 1:1000). The antigen and antibody
complexes on the Western blot were amplified by secondary
antibody conjugated with horseradish peroxidase (Bio-Rad,
Hercules, CA) and then detected with enhanced chemilu-
minescence plus (ECL-plus, Amersham Pharmacia Biotech,
Piscataway, NJ) followed by either autoradiography or
scanning with the Storm Phosphorimager (Amersham
Pharmacia Biotech). Quantitation of expression levels was
determined with Tiff files from scanned films by using the
BioMax 1D program (Kodak). Liver Cdk2 or h-actin
protein levels were used for normalization control for
Western blots.
Total RNA was prepared from embryonic mouse liver
using RNA-STAT-60 (Tel-Test bBQ Inc. Friendswood,
TX). Five micrograms of total liver RNA was used for
RNase protection assays (RPA) with antisense (a-32P)
UTP-labeled RNA probes made from Cyclin mCyc-1
template (BD Pharmingen; Catalog # 45620P) as
described previously (Wang et al., 2001a, 2002a). RNase
protection assays to measure Foxm1b mRNA levels were
performed with antisense-labeled RNA synthesized from
the mouse Foxm1b genomic probe as described previ-
ously (Wang et al., 2002a). Quantitation of expression
levels was determined with Tiff files from scanned films
by using the BioMax 1D program (Kodak). GAPDH
(RNA) expression signal was used for normalization
control between different liver samples.Results
Foxm1b / mouse embryos displayed defects in
hepatoblast mitosis, abnormal liver development,
and embryonic lethality
Mice heterozygous (+/) for the Foxm1b (or Foxm1)
deleted allele were generated by mating mice containing
the Foxm1b LoxP/LoxP (fl/fl) targeted allele (Fig. 1A)
with the EIIa promoter-driven Cre recombinase transgenic
mice (EIIa-Cre). The EIIa-Cre transgene exhibits transient
expression of the Cre Recombinase during the blastocyst
stage of mouse development (Lakso et al., 1996). This
cross produces chimeric mice that contain all of the
potential genomic deletions between the LoxP sites in the
targeted Foxm1b fl/fl allele (Fig. 1A). Chimeric male mice
generated from this cross that lacked the EIIa-Cre trans-
gene were bred with wild-type (WT) mice. Foxm1b +/
mice were selected containing the deleted targeted Foxm1b
allele that was missing exons 4 to 7 encoding the winged
helix DNA binding and transcriptional activation domains
(Fig. 1A). We screened for the Foxm1b deleted allele
using both Southern blot analysis (data not shown) and
PCR amplification with the primers 1, 2, and 3 indicated
in Fig. 1A and described in the Materials and methods.
Male and female Foxm1b +/ mice were bred to harvest
Foxm1b / embryos from pregnant mothers for analysis.
Deletion of Foxm1b exons 4 to 7 in the deleted allele brings
primers 1 and 3 in close proximity, allowing production of a
400-nucleotide PCR product only from the Foxm1b deleted
(/) allele (Fig. 1B; PCR 1+3 KO). The Foxm1b /
allele removes sequences homologous to primer 2 and
therefore primer 1 and 2 will only produce a 230-nucleotide
PCR product from the wild-type (WT) Foxm1b allele (Fig.
1B; PCR 1+2 WT). RNase protection assays (RPA) were
used to screen a panel of tissues for Foxm1b RNA levels.
Foxm1b / embryos lacked Foxm1b mRNA expression
in a variety of tissues examined (data not shown), and Fig.
1C depicts RNase protection assays showing that 15.5-dpc
Foxm1b / livers lacked detectable Foxm1b mRNA
levels.
We found that 75% of the Foxm1b / embryos died in
utero by 17.5 dpc with almost a complete embryonic
lethality by 18.5 dpc (Table 1). Although only a few
Foxm1b / embryos died by 15.5 dpc, all of the harvested
15.5-dpc Foxm1b / embryos displayed a gelatin-like
consistency (Table 1 and data not shown). On several rare
occasions, we did find one Foxm1b / embryo present at
17.5 or 18.5 dpc, but they were transparent with evidence of
hemorrhagic lesions and edema (Fig. 1D). In contrast,
Korver et al. (1998) reported no embryonic lethality in mice
containing a different Foxm1b / targeted allele that
inserted the PGK-neomycin gene into the third Foxm1b
exon without deleting any of the coding exons. One possible
explanation for the differences in viability of these different
targeted Foxm1b / embryos is that the Foxm1b targeted
Fig. 2. Foxm1b-deficient livers contain polyploid hepatoblasts. (A–L)
Hematoxylin and eosin (H&E) or albumin immunohistochemical staining
of embryonic livers at the indicated days postcoitum (dpc). Embryonic
livers from WT (A, C, E, G), Foxm1b/ (B. D, F, H), Foxm1b fl/fl (I, K),
or AFPp-Cre Foxm1b fl/fl (J, L) embryos were either H&E-stained (A–F, I–
J) or immunohistochemically stained with albumin-specific antibody
followed by nuclear counterstaining with hematoxylin (G–H, K–L). Arrows
indicate hepatoblasts that are polyploid in Foxm1b deficient livers.
Magnification: A–B, 100; C–D, 630; E–L, 400.
Table 1
Percent lethality of Foxm1b / embryos and AFPp-Cre Foxm1b fl/fl
embryos
Stage of mouse
development
Total
number of
embryos
Expected
number
of /
or cko
embryos
Number
of /
embryos
or Cre+
embryos
Percent
lethality of
/ or cko
embryos
13.5 dpc / 45 11 8 27%
15.5 dpc / 72 18 17 6%
17.5 dpc / 17 4 1 75%
18.5 dpc / 53 13 1 91%
13.5 dpc cko 15 7 8 12.5%
14.4 dpc cko 13 6 10 40%
15.5 dpc cko 20 10 14 71%
Abbreviations are as follows: dpc, days postcoitum; /, Foxm1b /;
cko, conditional knockout livers (AFPp-Cre Foxm1b /); Cre+, AFPp-
Cre recombinase.
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hypomorphic levels of functional Foxm1b protein.
Analysis of hematoxylin and eosin (H&E)-stained liver
sections showed that Foxm1b / livers displayed a
significant reduction in the number of large hepatic veins
compared to age-matched wild-type (WT) embryonic liver
sections as described in the Materials and methods (Fig.
1E). Embryonic Foxm1b / livers exhibited a severe
disruption in organization of the hepatic cords and sinusoids
(Figs. 2A–D and data not shown). This histological staining
also revealed abnormal cells containing enlarged nuclei
(Figs. 2D and F, arrows) that were not found in WT
embryonic livers (Figs. 2C and E). Liver sections from 15.5-
dpc Foxm1b / and WT embryos were subjected to
immunohistochemical staining with an antibody specific to
the albumin protein followed by nuclear counterstaining
with hematoxylin. This analysis demonstrated that the
Foxm1b / hepatic cells containing enlarged nuclei were
indeed albumin-positive hepatoblasts (Figs. 2G–H, arrows).
These results suggest that Foxm1b / hepatoblasts failed
to enter into mitosis but had previously reinitiated DNA
replication creating a polyploid phenotype (see below).
Previous characterization of Foxm1b / embryos
containing a different Foxm1b targeted allele, which did
not delete any of the coding exons, showed that embryonic
cardiomyocytes were also polyploid, and this phenotype led
to postnatal lethality presumably from circulatory failure
(Korver et al., 1998). Our Foxm1b / embryos, which
deleted Foxm1b exons encoding the DNA binding and
transcriptional activation domains, also exhibited severe
defects in heart development, and many of the embryonic
Foxm1b / cardiomyocytes were enlarged and polyploid
(data not shown). To determine whether hepatoblast-specific
deletion of the Foxm1b fl/fl targeted allele is sufficient to
cause embryonic lethality (Fig. 1A), we generated a-
fetoprotein (AFP) enhancer and albumin promoter and
enhancer (AFPp) Cre recombinase transgenic Foxm1b fl/fl
embryos (AFP Foxm1b /). Previous studies demonstra-
ted that AFPp-Cre begins to delete the LoxP/LoxP (fl/fl)targeted allele in embryonic hepatoblasts at 10 dpc and
completes deletion of the targeted allele by 15 dpc (Parviz et
al., 2002, 2003). Albumin-positive hepatoblasts with
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Foxm1b / livers (Fig. 2I–L, arrows). However, we did
not observe cardiomyocytes with enlarged nuclei in AFPp-
Cre Foxm1b fl/fl embryos, suggesting that Foxm1b defi-
ciency was contributing to the polyploid phenotype in the
developing heart (data not shown). The AFPp-Cre Foxm1b
/ livers exhibited developmental abnormalities similar to
those found in Foxm1b / livers (data not shown).
Likewise, we observed 40% lethality of the 14.5-dpc AFPp-
Cre Foxm1b fl/fl embryos and 70% of the AFPp-Cre
Foxm1b fl/fl embryos died by 15.5 dpc (Table 1). Parviz et
al. (2003) reported heterogeneity in the deletion efficiency
of the Hnf4 LoxP/LoxP (fl/fl) targeted allele using the same
AFPp-Cre recombinase transgene. AFPp-Cre Hnf4 fl/fl
embryos displayed either a mild liver phenotype corre-
sponding to incomplete deletion of the targeted allele or a
severe liver phenotype correlating with complete deletion of
the targeted allele in all hepatoblasts. Consistent with these
findings, we found that several AFPp-Cre Foxm1b fl/fl
embryos were viable at birth, and we attribute their survivalFig. 3. Diminished number of BrdU-positive and increased ploidy of embryonic F
PH3 immunofluorescent staining revealed that the embryonic AFPp-CRE Foxm1
chromosomes compared to age-matched Foxm1b fl/fl hepatoblasts. We performed
and Foxm1b fl/fl mouse embryos with the phosphohistone H3 (PH3) antibody.
Embryonic livers (14.5 dpc) from either Foxm1b fl/fl or AFPp-Cre Foxm1b 
antibodies against either albumin (FITC, green C–D) or BrdU (TRITC, red E–F)
dpc) from either WT or Foxm1b / embryos were also subjected to double albu
graphically in panel I. (I) Graph of percent BrdU–albumin double-positive hepatob
positive hepatoblasts were counted for each of three Foxm1b knockout embr
hepatoblasts in each of three embryonic WT livers. (J–K) No increase in ap
immunohistochemical staining of embryonic liver sections from AFPp-Cre Foxm1
shown) using antibody specific to activated cleaved caspase 3. Magnification: A–to incomplete hepatoblast deletion of the targeted Foxm1b
fl/fl allele by the AFPp-Cre transgene.
Diminished proliferation of Foxm1b / hepatoblasts
causes reduced number of hepatoblasts in embryonic
Foxm1b / liver
To examine whether the Foxm1b-deficient hepatoblasts
were truly polyploid, we performed immunofluorescent
staining of liver sections from AFPp-CRE Foxm1b fl/fl and
Foxm1b fl/fl mouse embryos with the phosphohistone H3
(PH3) antibody, which decorates condensed chromosomes
at the beginning of mitosis. Analysis of this PH3 immuno-
fluorescent staining revealed that the embryonic AFPp-CRE
Foxm1b / hepatoblasts with enlarged nuclei exhibited an
increased number of chromosomes at early stages of mitosis
compared to age-matched Foxm1b fl/fl hepatoblasts (Fig.
3A–B). These results demonstrated that embryonic
Foxm1b-deficient hepatoblasts with enlarged nuclei dis-
played a polyploid phenotype.oxm1b / hepatoblasts compared to WT hepatoblasts. (A–B) Analysis of
b / hepatoblasts with enlarged nuclei exhibited an increase number of
immunofluorescent staining of liver sections from AFPp-CRE Foxm1b fl/fl
(C–H) Diminished BrdU incorporation in Foxm1b-deficient hepatoblasts.
/ embryos were subjected to double immunofluorescence staining using
and also shown are the merged micrographs (G–H). Embryonic livers (15.5
min and BrdU immunofluorescence staining, and these data are quantitated
lasts for each of the indicated genotypes. Percent of BrdU–albumin double-
yonic livers and compared to percent of BrdU–albumin double-positive
optosis was found in Foxm1b / livers. Apoptosis was detected by
b fl/fl or Foxm1b fl/fl embryos and Foxm1b / or WT embryos (data not
H, 400; J–K, 100.
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livers, 2 h before harvesting the embryos, we injected the
pregnant mothers with bromodeoxyuridine (BrdU). To
identify 14.5-dpc hepatoblasts undergoing DNA replication,
we used embryonic liver sections for double immunofluor-
escent staining with a monoclonal BrdU antibody detected
by antimouse antibody conjugated to TRITC along with
rabbit antibody specific to albumin protein detected by
antirabbit antibody conjugated to FITC (Figs. 3C–H). We
found a 90% decrease in BrdU incorporation in polyploid
albumin-positive hepatoblasts of embryonic Foxm1b /
livers compared to albumin-positive hepatoblasts of WT
embryonic livers (Fig. 3I). Likewise, a 60% reduction in
BrdU incorporation was observed in the polyploid albumin-
positive hepatoblasts of embryonic AFPp-Cre Foxm1b /
livers (Figs. 3H, purple arrow; and 3I, graph) compared to
embryonic albumin-positive Foxm1b fl/fl hepatoblasts (Fig.
3G, white arrow). Furthermore, no increase in apoptosis wasFig. 4. Embryonic Foxm1b / livers contain fewer HNF4a-positive hepatoblas
positive hepatoblasts in Foxm1b / livers. The HNF4a antibody was used for im
/ (B), Foxm1b fl/fl (C), or AFPp-Cre Foxm1b / (D) livers. (E) Graph sh
Foxm1b / livers. Three 400 fields of HNF4a-positive cells were counted for
Magnification: A–D, 200.found in either embryonic AFPp-Cre Foxm1b / livers or
Foxm1b / livers as evidenced by immunostaining with
antibody specific to activated cleaved caspase 3 protein
(Figs. 3J–K and data not shown).
The reduction in proliferation of Foxm1b / hepato-
blasts resulted in the presence of fewer hepatoblasts in
embryonic Foxm1b / liver compared to embryonic WT
liver. To quantify this decrease, embryonic liver sections
from either Foxm1b / (straight knockout), AFPp-Cre
Foxm1b fl/fl (conditional knockout), WT, or Foxm1b fl/fl
(control) embryos were immunohistochemically stained with
an antibody specific to the nuclear HNF4a transcription
factor. At this stage of liver development, the HNF4a protein
is specifically expressed in hepatoblast nuclei (Parviz et al.,
2003). Our analysis revealed a 75% decrease in the number
of HNF4a-positive hepatoblasts in the embryonic Foxm1b
/ livers compared to age-matched embryonic WT livers
(Figs. 4A–G). Despite this reduction in the number ofts compared to embryonic WT livers. (A–D) Reduced number of HNF4a-
munohistochemical staining of embryonic WT (Foxm1b +/+; A), Foxm1b
owing that the number of HNF4a-positive hepatoblasts is diminished in
embryonic livers from each of three mouse embryos of different genotypes.
Fig. 5. Periportal hepatoblasts of embryonic Foxm1b / livers are not
correctly specified to become bile duct epithelial cells. (A–F) Periportal
Foxm1b / hepatoblasts exhibit undetectable cytokeratin staining.
Pancytokeratin antibody was used for immunofluorescent staining of
embryonic livers from Foxm1b / or WT embryos at 15.5 dpc (A–B)
or 18.5 (E–F) dpc, and Foxm1b fl/fl or AFPp-Cre Foxm1b fl/fl embryos at
14.5 dpc (C–D). We also performed either H&E staining (G–H) or Gata4
antibody (I–J) immunohistochemical staining of 18.5 dpc Foxm1b / and
WT liver sections. Defects in formation of intrahepatic bile duct were found
in embryonic Foxm1b / livers. Magnification: A–H, 200; I–J, 630.
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the size of embryonic Foxm1b / livers compared to WT
livers (data not shown) suggesting that hypertrophy of the
Foxm1b / hepatoblasts compensated for their reduced
number. Likewise, AFPp-Cre Foxm1b / livers displayed
a 50% decrease in the number of hepatoblasts compared to
livers from Foxm1b fl/fl littermates (Fig. 4G). However, the
fact that the embryonic AFPp-Cre Foxm1b fl/fl livers display
a less severe reduction in hepatoblast number compared to
the Foxm1b / livers suggests that the AFPp-Cre Foxm1b
fl/fl livers represent an intermediate state with partial
knockout. These studies suggest that the developmental
abnormalities of the Foxm1b-deficient livers are likely
caused by significant reduction in the numbers of bipotential
hepatoblasts which differentiate toward either the hepato-
cytic or biliary epithelial cell lineage (Lemaigre, 2003).
Abnormal development of intrahepatic bile ducts in Foxm1b
/ embryos
At 14.5 dpc in mouse liver development, periportal
hepatoblasts that coalesce around the portal vein mesen-
chyme begin to express biliary-specific cytokeratins and
undergo a complex developmental process that culminate in
the formation of intrahepatic bile ducts (IHBD) by 17.5 dpc
(Lemaigre, 2003). To determine whether IHBD develop
normally in Foxm1b / embryos, liver sections were
immunostained with cytokeratin antibody and visualized
using immunofluorescence as described previously (Kali-
nichenko et al., 2002). Livers sections from 14.5-dpc WT or
Foxm1b fl/fl mouse embryos showed characteristic cytoker-
atin expression localizing to hepatoblasts surrounding the
portal mesenchyme (Figs. 5A and C), and IHBD displayed
continued biliary cytokeratin staining in 18.5-dpc WT livers
(Fig. 5E). However, cytokeratin staining was undetectable in
portal hepatoblasts in developing Foxm1b / and AFPp-
Cre Foxm1b / livers (Figs. 5B, D, and F), and the
Foxm1b / livers failed to develop IHBD properly (Figs.
5E–H). The defect in IHBD formation occurred despite the
presence of endothelial cells and fibroblasts in the periportal
region of Foxm1b / livers as demonstrated by nuclear
expression of the Gata4 transcription factor (Figs. 5G–K).
Analysis of AFPp-Cre hepatocyte nuclear factor 1h
(HNF1b) / livers demonstrated that hepatoblast expres-
sion of HNF1h is critical for normal development of IHBD
(Coffinier et al., 2002). Liver sections from Foxm1b /
embryos were subjected to immunohistochemical staining
using an HNF1h-specific antibody to determine whether
portal Foxm1b / hepatoblasts expressed normal levels of
the HNF1h transcription factor. Abundant HNF1h nuclear
staining was found in portal hepatoblasts of embryonic WT
liver (Figs. 6A and C), whereas portal Foxm1b /
hepatoblasts staining of the HNF1h protein was predom-
inantly cytoplasmic (Figs. 6B and D). Because nuclear
staining of the HNF1h protein was absent in portal Foxm1b
/ hepatoblasts, it is likely that this transcription factor isinactive, a finding consistent with defects in IHBD
formation. Furthermore, we found fewer HNF1h-positive
hepatoblasts in the IHBD region of embryonic Foxm1b /
livers compared to embryonic WT liver (data not shown). In
contrast, both Foxm1b / and WT embryos displayed
similar nuclear staining patterns of HNF1h protein in
epithelial cells of the extrahepatic bile ducts (EHBD), which
were associated with normal development of EHBD in the
Foxm1b / embryos (Figs. 6E–F).
Fig. 6. Periportal Foxm1b / hepatocytes fail to express nuclear levels of
HNF1h transcription factor. (A–F) Embryonic periportal Foxm1b /
hepatoblasts display cytoplasmic staining of the HNF1h transcription
factor. HNF1h antibody was used for immunohistochemical staining of
15.5-dpc liver sections from Foxm1b / and WT littermate embryos. (A–
D) Micrographs show periportal embryonic hepatoblasts at either 400 (A–
B) or 630 magnification (C–D, with nuclei counterstained with
hematoxylin). (E–F) Extrahepatic bile ducts form correctly in 15-dpc
Foxm1b / embryos as evidenced by proper nuclear HNF1h staining.
Magnification: A–B, E–F, 200; C–D, 630.
K. Krupczak-Hollis et al. / Developmental Biology 276 (2004) 74–88 83Embryonic Foxm1b / livers show a decrease in
expression of Cdk1 activating Cdc25B and Polo-like and
Aurora B kinases, which are required for orchestrating
mitosis
Total RNA and protein extracts were isolated from livers
of 15.5-dpc WT and Foxm1b / embryos and used for
RNase protection assay and Western blot analysis to
determine the expression of several cell cycle regulators.
Embryonic Foxm1b / livers exhibited diminishedFig. 7. Embryonic Foxm1b / livers exhibit diminished expression of
Cdc25B, Cdk1, Polo-like kinase, and Aurora B kinase; all of which are
critical for orchestrating mitosis. (A) Foxm1b / livers exhibit diminished
RNA levels of Cyclin A2 and Cyclin B1. RNase protection assays with
liver RNA isolated from 15.5-dpc Foxm1b / liver and WT liver. (B–C)
Embryonic Foxm1b / livers exhibit diminished protein expression of
Cdc25B, Cdk1, Polo-like kinase, and Aurora B kinase. Western blot
analysis with liver protein extracts isolated from 15.5-dpc Foxm1b / and
WT embryos were performed with antibodies specific to Cdc25B, Cdk1,
Polo-like kinase, Aurora B kinase, albumin, and HNF6. Either Cdk2 or h-
actin protein levels were used as loading controls. Relative intensities of
Western blot signals were normalized to loading control, and embryonic
Foxm1b / hepatic protein levels were compared to WT protein levels
that were set to one. No differences in albumin and HNF6 protein levels
were found between Foxm1b / and WT embryonic livers.mRNA levels of the S-phase mediating Cyclin A2 and M-
phase-specific Cyclin B1 compared to embryonic WT liver
(Fig. 7A). Western blot analysis revealed undetectable
protein levels of Cdk1 activating Cdc25B phosphatase in
Foxm1b / embryonic liver extracts (Fig. 7B), and the
Cdc25B gene is a known downstream target of the Foxm1b
transcription factor (Wang et al., 2002a). The Polo-like
kinase 1 (Plk-1) phosphorylates a number of regulatory
proteins critical for mitosis that play a role in mediating
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cytokinesis (Glover et al., 1998). Consistent with the
reduction in Foxm1b / hepatoblast mitosis, Western blot
analysis revealed a 60% reduction in protein expression of
Polo-like Kinase 1 (Plk-1) in embryonic Foxm1b / liver
extracts compared to embryonic WT liver extracts (Fig. 7B).
Furthermore, an 80% reduction in protein levels of Aurora B
kinase was found in embryonic Foxm1b / liver extracts
compared to age-matched WT liver extracts (Fig. 7C). The
significant decrease in Aurora B kinase protein levels is
consistent with a reduction in Foxm1b / hepatoblast
mitosis because its activity is critical for orchestrating
various steps in mitosis and cytokinesis (Adams et al., 2001;
Carmena and Earnshaw, 2003; Shannon and Salmon, 2002).
The mitosis block observed in Foxm1b / hepatoblasts is
consistent with diminished expression of Cdc25B,
CyclinB1, Cdk1, Polo-like kinase, and Aurora B kinases,
which are critical for activating regulatory proteins, required
to orchestrate mitosis. Interestingly, Western blot analysis
revealed no detectable change in either albumin or HNF-6
protein levels between embryonic WT and Foxm1b /
liver extracts (Fig. 7B), suggesting that the Foxm1b /
hepatoblasts were not disrupted in hepatocyte specification.
We hypothesize that the larger Foxm1b / hepatoblasts
can store more albumin protein in their cytoplasm compared
to the much smaller WT hepatoblasts, and this increase
capacity compensates for reduction in the number of
hepatoblasts in Foxm1b knockout livers.Discussion
Liver regeneration studies with Alb-Cre Foxm1b /
mice demonstrated that Foxm1b is essential for high levels of
hepatocyte DNA replication and caused nearly a complete
block in mitosis by altering expression of proteins that are
required for cell cycle progression (Wang et al., 2002a). To
determine the role of the Foxm1b gene in embryonic liver
development, we have generated Foxm1b / mice that
deleted the Foxm1b exons encoding the winged helix DNA
binding and transcriptional activation domains. Almost all of
the Foxm1b / embryos died in utero by 18.5 dpc, and
Foxm1b / livers exhibited reduced number of large
hepatic veins and abnormal development of sinusoids.
Furthermore, embryonic Foxm1b / livers did not develop
intrahepatic bile ducts (IHBD), and these presumptive biliary
hepatoblasts failed to express biliary cytokeratins and the
HNF1h transcription factor was predominantly cytoplasmic.
Embryonic Foxm1b / livers exhibited a 75% reduction in
the number of hepatoblasts because they failed to progress
into mitosis, causing a polyploid phenotype. This is
supported by the fact that Foxm1b-deficient hepatoblasts
with enlarged nuclei possessed an increased number of
condensed chromosomes at early stages of mitosis compared
to control hepatoblasts as visualized by immunofluorescent
staining with phosphohistone H3 (PH3) antibody. Theinhibition of Foxm1b / hepatoblast mitosis was associ-
ated with undetectable levels of the Cdk1 activator Cdc25B
phosphatase and reduced expression of the Polo-like kinase 1
(Plk1) and Aurora B kinase proteins, all of which phospho-
rylate proteins that regulate activity of the mitotic machinery
(Adams et al., 2001; Carmena and Earnshaw, 2003; Glover et
al., 1998; Shannon and Salmon, 2002). Reduced activity and
levels of the Cdk1, Plk1, and Aurora B mitotic kinases in
Foxm1b / hepatoblasts are therefore consistent with
severe inhibition of hepatoblast progression through mitosis.
Finally, the AFPp-Cre Foxm1b fl/fl embryos died in utero
and exhibited diminished hepatoblast proliferation with
similar abnormalities in liver morphogenesis, suggesting
that the defect in liver development contributed to embryonic
lethality.
Stimulation of Cdk1 activity requires complex formation
with Cyclin B proteins and dephosphorylation of the Y15 and
T14 residues of the Cdk1 protein by the Cdc25B and Cdc25C
phosphatases (Nilsson and Hoffmann, 2000; Sebastian et al.,
1993; Trembley et al., 1996). The onset of mitosis is marked
by nuclear translocation and activation of Cyclin B–Cdk1
complexes which function to phosphorylate proteins
involved in nuclear envelope breakdown (lamins), chromo-
some condensation, chromosome segregation, and cytokine-
sis (Blangy et al., 1995; Kimura et al., 1998; Nigg, 2001; Ohi
and Gould, 1999; Ookata et al., 1993; Sutani et al., 1999).
Activation of Cdc25B phosphatase initiates at late S-phase,
peaks during G2 phase, and is believed to initiate G2/M
transition by stimulating kinase activity of the Cdk1–Cyclin
B protein complex (Lammer et al., 1998). The Cdc25C
phosphatase maintains Cdk1 activity throughout mitosis by
dephosphorylating these inhibitory Thr/Tyr residues and is
activated at mitosis via phosphorylation by Cdk1–Cyclin B
complex and Polo-like kinase proteins (Glover et al., 1998;
Hoffmann et al., 1993; Izumi andMaller, 1993).Foxm1b/
livers exhibit undetectable levels of Cdc25B and a 60%
reduction in Plk1; the latter of which would diminish
activation of Cdc25C phosphatase (Glover et al., 1998).
Based on these published studies, it is therefore likely that
diminished activation of Cdk1–Cyclin B protein complex
contributes to the reduced hepatoblast mitosis found in
embryonic Foxm1b / livers.
Diminished progression of Foxm1b / hepatoblasts
into mitosis is consistent with significant reduction in
expression of the Polo-like kinase 1 (Plk1) and Aurora B
kinase proteins. Immunofluorescent staining shows that
Plk1 protein localizes to the centrosomal region of
chromosomes and mitotic spindles and to the central
spindle region in late anaphase and midbody region in
telophase (Glover et al., 1998). Biochemical and genetic
studies demonstrate that Plk-1 is critical for mitotic spindle
formation and mediating proper chromosome segregation
during the metaphase to anaphase transition and is critical in
mediating cytokinesis (Glover et al., 1998). Aurora B
kinase phosphorylates critical substrates to execute mitosis
that include orchestrating chromosome condensation, phos-
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segregation, mitotic spindle dynamics, and cytokinesis
(Adams et al., 2001; Carmena and Earnshaw, 2003;
Shannon and Salmon, 2002). The chromosome passenger
proteins inner centromere protein (INCENP) and Survivin
form a complex with Aurora B kinase. Activation of Aurora
B kinase is mediated by INCENP phosphorylation, and
ectopic expression of Aurora B kinase containing a
mutation in this INCENP phosphorylation site blocks
cytokinesis during mitosis (Yasui et al., 2004). Immuno-
fluorescent staining shows that these chromosome passen-
ger proteins decorate the length of chromosomes at
prophase, become restricted to the inner chromosomal
region during metaphase, and relocalize to the central
spindle during anaphase (Shannon and Salmon, 2002).
Overexpression of a kinase-dead mutant of Aurora B
protein in mammalian cells caused defects in the kinet-
ochore assembly with dynein and CENP-E motor proteins
and loss of microtubule attachment to the kinetochores
(Murata-Hori et al., 2002; Murata-Hori and Wang, 2002).
Inhibition of Aurora B kinase activity also caused prema-
ture exit from mitosis without progression into anaphase or
cytokinesis and with reentry into S-phase (Murata-Hori and
Wang, 2002; Murata-Hori et al., 2002). Significant
decreases in protein levels of Plk1 and Aurora B kinase
in Foxm1b / hepatoblasts are thus consistent with
blockage in the progression through mitosis and reinitiation
of S-phase, resulting in a polyploid phenotype.
Embryonic Foxm1b / livers exhibit a diminished
number of intrahepatic bile ducts (IHBD), and the periportal
hepatoblasts failed to express biliary cytokeratins and
differentiate toward the biliary epithelial cell lineage.
Interestingly, although Foxm1b / livers exhibit severe
defects in IHBD formation, we found that extrahepatic bile
ducts (EHBD) developed normally in Foxm1b /
embryos. Genetic studies demonstrated that Hnf6 /
mouse embryos fail to develop a gall bladder and exhibited
severe abnormalities in both extrahepatic and intrahepatic
bile ducts, which was associated with diminished expression
of the Hnf1b transcription factor (Clotman et al., 2002;
Jacquemin et al., 2000). Analysis of conditionally hepato-
blast deleted AFPp-Cre Hnf1b fl/fl embryos also caused
developmental abnormalities in the gall bladder and IHBD
similar to but less severe than those found in the Hnf6 /
mouse embryos (Coffinier et al., 2002). Although Foxm1b
/ liver extracts exhibited normal protein levels of HNF6
as determined by Western blot analysis, staining of the
Hnf1b protein was predominantly cytoplasmic in periportal
Foxm1b / hepatoblasts, suggesting that this transcription
factor may not be functional in the Foxm1b knockout
hepatoblasts. These results suggest that nuclear localization
of Hnf1b protein is either directly or indirectly regulated by
the Foxm1b transcription factor or that nuclear translocation
of the Hnf1b protein requires cellular proliferation. Taken
together, our results indicate that, in addition to a defect in
hepatoblast proliferation, Foxm1b may also contribute to thedifferentiation of hepatoblasts toward the cholangiocyte or
biliary epithelial cell lineage.
Although Foxm1b / embryos exhibit a severe defect
in heart development, we also observed lethality of AFPp-
Cre Foxm1b fl/fl embryos containing a hepatoblast-specific
deletion of the Foxm1b targeted allele, suggesting that the
defect in liver development contributed to embryonic
lethality. We found that Foxm1b deficiency did not inhibit
hepatoblast specification as evidenced by normal protein
levels of albumin. One possible explanation for Foxm1b
/ embryonic lethality is that diminished number of
large hepatic veins and disruption of hepatoblast–sinusoid
structure will reduce liver function and limit the ability of
Foxm1b / livers to secrete hepatic serum proteins and
clotting factors into the fetal circulation as required for
homeostatic function. This possibility is consistent with the
observation that 17.5-dpc Foxm1b / embryos exhibited
both hemorrhagic lesions and edema. Because the liver is
an important fetal organ for development of hematopoeitic
cells (Kaufman, 1992), it is possible that a defect in
formation of red blood cells may play a role in lethality of
Foxm1b / embryos. Inspection of the embryonic
Foxm1b / livers indicated no significant reduction in
the number of mature erythrocytes or reticulocytes, and the
Foxm1b / embryos do not appear anemic (data not
shown). However, we cannot rule out the possibility that
the defect in liver architecture is causing embryonic
lethality through abnormal development of one or more
other hematopoeitic cell types that originate from hema-
topoeitic stem cells residing in the liver.
Although Foxm1b / embryos exhibited severe defects
in liver and heart development, initiation of liver and heart
morphogenesis was not inhibited in Foxm1b / embryos.
With a few exceptions, most of the other organs developed
normally in Foxm1b / embryos. These results suggest
that Foxm1b may not be required for mitosis during early
stages of embryogenesis and organogenesis, and regulation
of embryonic cell proliferation may differ from that found in
adult organs and in tissue culture cells. This hypothesis is
supported by the fact that Cdk2 / mice are viable and
survive for up to 2 years, indicating that CDK2 is
dispensable for cell proliferation during embryonic develop-
ment and in adult life (Berthet et al., 2003; Ortega et al.,
2003). However, these studies demonstrated that CDK2 is
essential for meiotic cell division in male and female germ
cells resulting in sterility. Moreover, Cyclin E1 and Cyclin
E2 knockout mice are viable, and double knockout embryos
died in utero, yet they showed no overt defects in cell
proliferation but rather died because of defects in placental
function (Geng et al., 2003; Parisi et al., 2003). Although
Cyclin A2 / embryos die in utero at 5.5 dpc, these
embryonic cells proliferate during early development
despite the absence of the Cdk2–Cyclin A2 cell cycle
regulatory protein (Murphy et al., 1997). Taken together,
these results indicate that mouse development and organo-
genesis proceeded normally in mouse embryos containing
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genes, whose expression is critical for regulating cell cycle
progression in vitro. In a manner consistent with that
reported in these other knockout studies, we found that
proliferation of embryonic cells proceeded normally during
early development and organogenesis in Foxm1b /
embryos. However, diminished proliferation of hepatoblasts
and cardiac myocytes in Foxm1b / embryos contributed
to severe defects in liver and heart development leading to
embryonic lethality.
A number of proliferation-specific transcription factors
play a critical role in mediating survival of hepatoblasts
during liver development (Costa et al., 2003; Duncan,
2003). For example, disruption of the c-Jun gene results in
embryonic lethality at 13 dpc resulting from extensive
apoptosis of hepatoblasts and hematopoeitic cells that reside
in mouse embryonic livers at this stage of mouse develop-
ment (Eferl et al., 1999; Hilberg et al., 1993). Furthermore,
liver degeneration and hepatoblast apoptosis were found in
mouse embryos that are disrupted in the signaling pathway
that activates the NFnB transcription factor (Beg et al.,
1995; Rudolph et al., 2000; Tanaka et al., 1999). Unlike
these other proliferation-specific transcription factors, the
Foxm1b transcription factor was not required for the
survival of the hepatoblasts because we found no significant
increase in apoptosis in either embryonic Foxm1b /
livers or embryonic AFPp-Cre Foxm1b / livers. Rather,
Foxm1b is required for the proliferative expansion of
hepatoblasts necessary for liver morphogenesis.
Recently, our laboratory used a diethylnitrosamine
(DEN)/phenobarbital (PB) liver tumor induction protocol
to demonstrate that Alb-Cre Foxm1b / mouse hepato-
cytes fail to undergo proliferation and are highly resistant to
developing HCC following DEN/PB liver tumor induction
(Kalinichenko et al., 2004). Furthermore, we showed that
conditional overexpression of Foxm1b protein in osteosar-
coma U2OS cells stimulated anchorage-independent growth
of U2OS cells on soft agar, suggesting that increased levels
of Foxm1b are also involved in oncogenic transformation
(Kalinichenko et al., 2004). The critical role played by
Foxm1b in the proliferative expansion of liver tumors and in
stimulating anchorage-independent growth is consistent
with our current study demonstrating that Foxm1b mediates
hepatoblast proliferation and migration required for liver
morphogenesis.
In summary, we demonstrated that Foxm1b is essential for
embryonic viability and for normal development of IHBD,
hepatic vessels, and sinusoids. We showed that embryonic
Foxm1b / livers displayed a 75% reduction in the number
of hepatoblasts because they failed to progress into mitosis
and became severely polyploid. Inhibition of Foxm1b /
hepatoblast mitosis was associated with undetectable levels
of the Cdk1 activator Cdc25B phosphatase and reduced
expression of the Polo-like kinase 1 (Plk1) and Aurora B
kinase proteins; all of which are required to orchestrate
progression through mitosis and cytokinesis.Acknowledgments
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